Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 28Colorectal Neoplasms 13Colonic Neoplasms 13Rectal Neoplasms 9Prostatic Neoplasms 7Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Melanoma 5Endometrial Neoplasms 5Central Nervous System Neoplasms 5Ovarian Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Pancreatic Neoplasms 3Neuroblastoma 3Liver Neoplasms 3Liposarcoma 3Hemangiosarcoma 3Hemangiopericytoma, Malignant 3Gallbladder Neoplasms 3Fibrosarcoma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Hepatocellular 3

Interventions

Surgical Procedures, Operative 1Fluorouracil 1Drug Therapy 1Cisplatin 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Localized Resectable Adult Primary Liver Cancer × Chemotherapy, Adjuvant × Clear all
NCT00238160 2013-05-30

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

National Cancer Institute (NCI)

Phase 3 Withdrawn

Localized Resectable Adult Primary Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡